Male Reproductive System

Anatomy

Male reproductive anatomy overview: focus on parts, functions, and potential disorders; comparison with female anatomy is noted but the emphasis is on male structures.
Scrotum
- A pendulous sac that hangs outside the body; houses the testes.
- Function: maintains testes at a temperature lower than core body temperature to support spermatogenesis.
- Cooling mechanisms: sweat glands in the scrotum help keep the testes cool.
Testes (testis)
- Primary male gonads; there are typically 2 testes.
- Main functions:
- Produce sperm (spermatozoa).
- Produce testosterone (dominant male sex hormone).
- Cells:
- Leydig cells produce testosterone.
- Seminiferous tubules within the testes produce sperm.
- Sperm production occurs within millions of seminiferous tubules in the testes.
Seminiferous tubules
- The structural unit inside the testis responsible for spermatogenesis.
Epididymis
- Structure on top of the testis; a long tubule about 20 feet long.
- Function: site of sperm maturation; sperm gain motility and fertilizing capability over several days.
- After maturation, sperm move into the vas deferens.
Vas deferens (ductus deferens)
- A long secretory/transport duct that carries sperm from the epididymis toward the urethra.
- Function: propels sperm and contributes to semen by adding seminal fluids.
Seminal vesicles
- Gland located near the prostate; contribute about ~60% of semen volume.
- Secretions include mucus, nutrients (glucose), enzymes, and prostaglandins; support sperm viability.
Prostate gland
- Walnut-shaped gland located by the neck of the bladder; surrounds the urethra.
- Secretions contribute to alkaline, milky fluid (semen) that helps sperm viability.
- Prostate fluid is typically thin and milky; seminal vesicle fluid is thicker.
Cowper’s (bulbourethral) glands
- Pea-sized glands located just below the prostate.
- Secrete clear mucus that provides lubrication during sexual activity.
Urethra and meatus
- Urethra carries urine from the bladder and semen from reproductive tract to the exterior.
- Meatus: the external opening of the urethra.
Ejaculatory duct
- Formed by the joining of the vas deferens and the seminal vesicle ducts.
- Passes semen into the prostatic urethra during ejaculation.
Penis anatomy (relevant parts)
- Cylindrical organ with glans (the tip) – glans is the distal end.
- Tissues:
- Corpora cavernosa: dorsal erectile tissue; primary site for erection.
- Corpus spongiosum: ventral erectile tissue surrounding the urethra; helps keep urethral opening intact during erection.
Blood supply and erection-related anatomy
- Erection involves engorgement of corpora cavernosa and corpus spongiosum with blood.
- The transcript notes corpora cavernosa and corpora spongiosum as key erectile tissues.
Common anatomical disorders to anticipate
- Cryptorchidism (cryptorchidism): undescended testis; an emergency if not descended by birth or shortly after.
- Testicular descent typically occurs before birth; failure to descend may require surgical correction.
- Disorders of the epididymis, vas deferens, or surrounding structures can affect fertility.

Physiology of the male reproductive system

Primary physiological functions
- Spermatogenesis: production of sperm.
- Erection: vascular changes that allow penis to become rigid for intercourse.
- Emission: movement of sperm and accessory fluid into the pelvic urethra.
- Ejaculation: expulsion of semen through the urethra.
Spermatogenesis
- Definition: production of sperm.
- Onset: functional spermatogenesis begins around age 13.
- Hormonal control: testosterone from the testes stimulates germinal cells to become spermatocytes; maturation continues thereafter.
- Temperature requirement: sperm require a cooler environment than core body temperature.
Testosterone and testicular cells
- Testosterone is produced by the testicular Leydig cells (in the transcript, the term used is inconsistent; Leydig cells are the actual testosterone producers).
- Testosterone effects: development of male secondary sexual characteristics (facial/body hair, muscle mass, etc.).
Cryptorchidism (cryptorchidism)
- Definition: undescended testis; May be unilateral or bilateral.
- Clinical concern: remains at higher abdominal temperature, increasing risk for infertility and testicular cancer if not corrected.
- Management: may require surgical correction; timing often around early infancy.
Erection physiology (note on context)
- In the transcript: erection is described as a response mediated by the sympathetic nervous system; in standard physiology, erection is primarily mediated by parasympathetic (pelvic splanchnic) activation with nitric oxide–mediated vasodilation.
- Goal: maintain an adequate blood supply to the corpora cavernosa for sexual function.
Emission and ejaculation
- Emission: release of sperm and accessory gland fluid into the pelvic urethra.
- Ejaculation: expulsion of semen from the urethra to the exterior.
Post-physiology takeaways
- The male reproductive system remains capable of sexual function into older age, but hormonal changes can occur (testosterone decline after ~late 40s/50s) with slower arousal and longer refractory periods.
- Reproductive health considerations persist into older age; consult a reproductive physiologist for concerns like erection problems.

Health history, assessment, and risk factors

Health history focus
- Ask about primary problem (pain, weight changes, fertility/infertility, erectile dysfunction, self-image issues, masses in the genital area).
- Pain assessment: use a 0–10 scale for pain; note degree and location.
- Past medical history: diabetes, cancer, pituitary injuries, other endocrine or neurological issues.
- Family history: genetic predispositions (e.g., prostate cancer, diabetes, hypertension, stroke, bleeding disorders).
- Review of systems: assess skin lesions, bleeding, drainage, itching, appetite, weight, activity levels.
- Medications: note drugs that affect sexual function or cause priapism or urinary symptoms (e.g., PDE-5 inhibitors, anticoagulants).
Etiology and epidemiology context
- Prostatic disorders are common in aging males; some conditions are age-related (e.g., BPH, prostatitis).
- STI exposure can be linked to epididymal or prostatitis-type symptoms.
Practical and ethical considerations
- Sexual health discussions require privacy and sensitivity.
- Screening and early detection for cancer (e.g., PSA for prostate cancer) have important implications for life expectancy and treatment choices.

Physical examination and clinical assessment procedures

Observation of externally visible structures
- Penis: assess appearance, circumcised vs uncircumcised status, any lesions or openings misalignment.
- Scrotum: color, wrinkles, symmetry; palpate testicles on both sides for consistency and size.
Transillumination examination of the scrotum
- In a darkened room with a light, transilluminate the scrotum to differentiate solid from fluid-filled masses.
- Hydrocele: fluid-filled mass that transilluminates (appears red under the light).
- Hydrocele is a non-emergency fluid accumulation; differentiate from hernia.
Hernia assessment
- Hernia involves abdominal contents protruding through the abdominal wall; advise against heavy lifting depending on the condition.
Prostate examination
- Palpation of the prostate gland via rectal exam to assess size, consistency, and presence of nodules or tenderness.
- Hyperplasia: characterized by enlargement of the prostate; can compress the urethra leading to obstructed urine flow.
Rectal findings
- Rectal prolapse or hemorrhoids can be evaluated during the exam.
Special considerations
- Circumcision status and hygiene considerations; circumcision may be performed for hygiene or cultural reasons.
Diagnostic testing and rationale for tests
- Why specialized diagnostics: fertility assessment, cancer screening, assessment of structural abnormalities, infection, and inflammation.
- Cancer screening aims: early detection improves treatment outcomes and survival.
- Endocrine evaluation helps determine testosterone levels and related hormonal status.
- Biopsy and imaging assist in confirming cancer diagnoses and staging.

Diagnostic tests and imaging modalities

Semen analysis (fertility testing)
- Preparation: abstain from sexual activity for $2-3$ days prior to collection.
- Sample collection: semen sample collected and delivered to lab within $1{ hour}$ .
- Parameters assessed: volume, viscosity (thickness), color, pH (alkaline in semen), sperm concentration (count), motility, and morphology.
- Sperm appearance: typical structure includes head, midpiece, tail; normal motility and morphology are essential for fertilization.
Endocrine studies
- Key hormone: testosterone level; essential for spermatogenesis and secondary sexual characteristics.
- Prolactin: males produce some prolactin; elevated prolactin can cause gynecomastia (breast development) and affect gonadal function.
Tumor markers
- Prostate-specific antigen (PSA): a protein produced by the prostate gland; elevated levels can indicate prostate cancer or other prostate disorders.
- PSA thresholds (contextual rules): recommended levels vary by age and clinical guidelines, with higher thresholds invoking further diagnostic investigation.
- Screening recommended for men at average risk around age $50$ with life expectancy at least $10$ years, and earlier for higher risk groups (e.g., family history) as discussed.
- PSA > $\frac{4mg}{ml}$ raises suspicion for cancer; PSA > $\frac{10mg}{ml}$ increases likelihood of cancer or metastasis.
General laboratory tests
- Urinalysis to assess infection, blood, proteins, or other indications of urinary tract issues.
- Calcium level: elevated calcium can indicate bone metastasis from prostate cancer; typically, calcium is higher in bone than in serum unless metastasis occurs.
- CBC (white blood cells): normal WBC range is roughly $5 imes 10^3$ to $1 imes 10^4$ cells/μL; elevations suggest infection or inflammation.
Radiological and advanced imaging
- CT scan: rapid, can assess metastasis in prostate or testicular cancers.
- Ultrasound:
- Scrotal ultrasound to detect masses within the scrotum or testicles.
- Transrectal ultrasound (TRUS) to visualize prostate, epididymis, and surrounding structures; often used to guide biopsies.
- MRI: detailed soft-tissue imaging; valuable for epididymal inflammation (epididymitis) and other pelvic pathologies.
- Radionuclide imaging (nuclear medicine): used in certain staging scenarios.
Biopsy
- TRUS-guided prostate biopsy to obtain tissue for histology when cancer is suspected.
Note on terms
- Transrectal ultrasound is abbreviated as TRUS; TURP is Transurethral Resection of the Prostate; TUMT is Transurethral Microwave Therapy; TUNA is Transurethral Needle Ablation; TUVP is Transurethral Vaporization of the Prostate; TURF/TURP terminology is used interchangeably in some contexts.

Treatments and interventions

Medication classes for lower urinary tract symptoms due to BPH
- 5-alpha reductase inhibitors: Finasteride, Dutasteride
- Function: shrink prostate tissue by inhibiting conversion of testosterone to dihydrotestosterone (DHT).
- Alpha-1 blockers (uroselective names include Tamsulosin, Alfuzosin; examples in transcript include Flomax [brand name for Tamsulosin], Doxazosin, Terazosin)
- Function: relax smooth muscle in bladder neck, prostate capsule, and prostatic urethra to improve urine flow and reduce obstruction.
- Other noted agents: a long-term therapy like Finasteride can be used in combination with alpha blockers; a long-term therapy named in transcript (Fidelofil) may be referring to erectile/dysfunction-related agents; common ED medications include Sildenafil (Viagra), Tadalafil (Cialis), Vardenafil (Levitra).
- Dosing timing: some agents are preferably taken at bedtime to reduce side effects like hypotension or syncope.
- Counseling on ejaculation changes and monitoring for side effects.
Minimally invasive procedures for BPH
- TURP: Transurethral Resection of the Prostate – surgically removes prostate tissue blocked by BPH via urethral approach.
- TUMT: Transurethral Microwave Therapy – microwave heat ablates excess prostate tissue.
- TUNA: Transurethral Needle Ablation – uses needles to ablate tissue.
- TUVP: Transurethral Vaporization of the Prostate – vaporization of obstructing tissue.
- Prostate stent: temporary relief by keeping urethral lumen open.
- Electrovaporization and other debulking methods.
Radical interventions
- Prostatectomy (radical): surgical removal of the prostate for cancer management or severe disease.
- Orchiectomy (orchidectomy): removal of one or both testes, used for certain cancer or hormonal management strategies.
Erectile dysfunction management (general approach)
- Hormonal therapy (testosterone) may be considered in some contexts.
- Psychological support and counseling.
- Pharmacologic treatments: PDE-5 inhibitors (e.g., Sildenafil, Tadalafil, Vardenafil).
- Other therapies: denial implants (likely “penile implants”); injectable therapies.
Complications and nursing considerations after procedures
- Postoperative catheter management: indwelling urinary catheter with possible continuous bladder irrigation to prevent clots.
- Watch for infection, fever (> $101^{e}{F}$ ) or > $38.3^{e}{C}$ , bleeding, and dehydration.
- Education on lifestyle adjustments, rest, hydration, and recognizing warning signs.
Prostate cancer-specific management (overview)
- PSA is used for screening; high levels prompt further testing.
- Treatments depend on stage: radical prostatectomy, radiation therapy, hormonal therapy, or combination therapies; metastasis may require systemic treatment.
Testicular cancer management (overview)
- Early detection via self-examination; imaging (CT) and tumor markers used for staging.
- Hormonal therapy may be used in certain cases.

Common disorders and conditions (high-yield overview)

Prostatitis (inflammation of the prostate)
- Types: I–IV (acute bacterial, chronic bacterial, chronic prostatitis/chronic pelvic pain syndrome, asymptomatic inflammatory prostatitis).
- Symptoms: discharge, burning on urination, pelvic or perineal pain, urinary symptoms.
- Common causes: bacteria (e.g., E. coli), STIs, mumps, urinary catheterization history; acute presentations may be bacterial.
- Diagnostics: urinalysis, culture, CBC (WBC elevated in infection).
- Treatment: antibiotics (e.g., fluoroquinolones like levofloxacin for bacterial prostatitis); symptomatic care.
Epididymitis
- Inflammation of the epididymis; symptoms include scrotal pain and swelling with radiating pain to the groin; pain with ejaculation; scrotal tenderness.
- Common causes: STI pathogens (gonorrhea, chlamydia) and other infections (E. coli, TB) or viral etiologies (mumps);
- Diagnosis: scrotal exam, scrotal ultrasound with Doppler; exam for epididymal enlargement.
- Treatment: antibiotics if bacterial; supportive care; vaccination and STI prevention as preventative measures.
Orchitis
- Inflammation of one or both testes; symptoms: chills, fever, nausea/vomiting, general malaise; scrotal swelling and tenderness; acute pain.
- Causes: STI pathogens; mumps virus as a viral cause.
- Diagnosis/treatment: ultrasound Doppler; antibiotic therapy if bacterial; supportive care for viral infections; manage inflammation.
Benign prostatic hyperplasia (BPH)
- Non-malignant enlargement of the prostate.
- Symptoms: urinary obstruction, difficulty initiating urination, weak urinary stream, incomplete bladder emptying.
- Risks: bladder outlet obstruction can lead to hydronephrosis or kidney infection if untreated.
- Diagnostics: history, digital rectal exam, urinalysis, PSA testing, urine flow testing, post-void residual measurement, 24-hour voiding diary, biopsy if indicated.
- Treatments: lifestyle modifications; medications as above; surgical options (TURP, TURF/TURP, TURMT, TUNA, TUVP); radical options if cancer coexists.
Prostate cancer
- Second leading cause of cancer-related death in males; early detection is key.
- Risk factors: race (higher in Black men), age (> $50$ ), family history (father or brother with prostate cancer), diet and genetics.
- Screening: PSA testing; TRUS biopsy; imaging for staging (CT, MRI).
- PSA interpretation: PSA > $\frac{4mg}{ml}$ suggests cancer risk; PSA > $\frac{10mg}{ml}$ raises concern for possible metastasis.
- Treatment options: radical prostatectomy, radiation therapy, hormonal therapy; stage-guided approach; prevention: no proven method to completely prevent, but lifestyle and health maintenance recommended.
Penile cancer
- Risk factors: uncircumcised status, HPV infection, STIs; presents as a painless lesion on the penis that does not respond to antibiotics.
- Management: surgical removal, circumcision in some cases, possible lymph node management depending on spread.
Testicular cancer
- Early detection through self-examination; imaging and tumor markers for staging; treatment may include surgery, chemotherapy, or radiation depending on stage.
Infertility, erectile dysfunction, and related conditions
- Infertility: defined as failure to achieve pregnancy after $12$ months of unprotected intercourse (or earlier in certain high-risk groups).
- Erectile dysfunction (impotence): issues with achieving or maintaining an erection; multifactorial including vascular, hormonal, psychological factors; management includes lifestyle modifications, medications (PDE-5 inhibitors), injections, implants, and counseling.
- Priapism: prolonged erection requiring emergency attention (if lasting > $4-6$ hours or not resolving with standard measures); risk of penile ischemia and tissue damage if not treated promptly.
- Peyronie’s disease: fibrous plaque within tunica albuginea leading to curvature and painful erections; can be due to injury or scarring.
- Phimosis and paraphimosis: foreskin retraction issues due to edema; management includes hygiene measures and possible circumcision.
Reproductive health ethics and patient education considerations
- Emphasize privacy, consent, and sensitive communication.
- STI screening, safe sex practices, and vaccination (e.g., mumps prevention) when appropriate.
- Regular screening and shared decision-making about PSA testing and cancer screening, particularly in higher-risk populations.

Key numerical references and formulas (LaTeX-formatted)

Spermatogenesis onset age: ${around }13{ years}$
Epididymal length: $L\approx20{ feet}$
Semen volume and pH: analyte measures include $V_{{semen}}$ and ${pH}\text{(alkaline)}$ ; semen is typically alkaline due to contributions from the prostate.
PSA thresholds for screening and cancer risk:
- If PSA is elevated above $4ml$ , cancer risk is considered; higher thresholds (e.g., $>10\ m\text{g/mL}$ aise suspicion for more advanced disease or metastasis.
Normal leukocyte count baseline: $5\times10^3\leq{WBC}\,/\,\mu L\leq1\times10^4$
Post-void residual volume measurements are obtained by ultrasonography; values indicate remaining urine after urination.
Fever threshold referenced: up to $101^\circ\text{F}$ (≈ $38.3^\circ\text{C}$ ) used in clinical discussions for postoperative monitoring.
Common clinical timeframes: abstinence before semen analysis: $2-3\text{ days}$ ; anesthesia duration for TURP: typically ~ $1\text{ hour}$ ; hospital stay after TURP often $2\text{ days}$ .
Prostate treatment thresholds and targets:
- PSA and cancer risk, treatment decisions depend on stage and comorbidity; radical prostatectomy, radiotherapy, or hormonal therapy are used depending on cancer stage.